1-3 of 3
Parameswaran Venugopal, M.D.
Close
Sort by
Journal Articles

The Role of FDG-PET in Hodgkin Lymphoma S/P Autologous Hematopoietic Cell Transplant (HCT) as a Predictor of Outcome.

Neel B. Shah, MD, Mohamed Farhat, M.D., Arti Lakhani, M.D., Daniel Mcfarland, D.O., Parameswaran Venugopal, M.D., Stephanie A Gregory, M.D., Jamile Shammo, M.D., John Maciejewski, M.D., Hande Tuncer, M.D., Henry C Fung, M.D.
Journal: Blood
Blood (2008) 112 (11): 2178.
https://doi.org/10.1182/blood.V112.11.2178.2178
Published: 2008
Journal Articles

A Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine Plus Mitoxantrone Followed by Yttrium-90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) and Maintenance Rituximab as Front Line Therapy for Patients with Intermediate or High Risk Follicular Non-Hodgkin’s Lymphoma.

Stephanie A. Gregory, MD, Mohamad Kassar, M.D., Henry C. Fung, M.D., Parameswaran Venugopal, M.D., Teresa M. O’Brien, Michelle Tenuto
Journal: Blood
Blood (2007) 110 (11): 1360.
https://doi.org/10.1182/blood.V110.11.1360.1360
Published: 2007
Journal Articles

Correlative Study of ZAP-70 Gene Expression by Quantitative PCR and CD-38 Surface Marker in Patients with Chronic Lymphocytic Leukemia (CLL).

Melissa L. Larson, M.D., Jamile M. Shammo, M.D., Sari H. Enschede, M.D., Parameswaran Venugopal, M.D., Daniel Russell, John S. Coon, IV, M.D., Ph.D., Stephanie A. Gregory, M.D.
Journal: Blood
Blood (2004) 104 (11): 4796.
https://doi.org/10.1182/blood.V104.11.4796.4796
Published: 2004